Atlas Trials

Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Clinical trial NCT05147844 · RECRUITING

Trial details

NCT number
NCT05147844
Sponsor
Xinqiao Hospital of Chongqing
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2022-03-01
Primary completion
2025-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.